Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona.

	Organisation	Laboratorio Reig Jofré S.A.
	Product	pharmaceutical
	Person	Martí, Laura (Reig Jofré 202312– CFO before Audax Renovables + General Electric)

REIG JOFRE, (BME:RJF), a pharmaceutical company listed on the continuous market of the Spanish stock exchange appoints Laura Martí as its new Chief Financial Officer (CFO).

Laura Martí holds a degree in Business Sciences from the Universitat Rovira i Virgili in Tarragona (Spain). Furthermore, she completed an international program in Business Administration at Clemson University in South Carolina, United States. Her education was further enhanced with a Global Executive MBA from the IESE Business School in Barcelona.

With over 20 years leading the financial direction at the renowned multinational corporation General Electric, Laura has held key roles in various industrial sectors within GE, including energy and healthcare. Her expertise covers different geographical locations, encompassing the United States, Switzerland, France, the United Kingdom, Italy, Brazil, and Mexico.

Over the past two years, following her return to Barcelona, Laura joined the publicly listed company on the continuous market, Audax Renovables, serving as the Group's Global CFO.

Her international and multifunctional leadership, combined with her experience in capital markets, has been centered around defining and implementing high-impact business and financial strategies, specializing in global-scale operations, services, and digital technology.

With this appointment, REIG JOFRE reaffirms its commitment to consolidating the company's presence and positioning in the stock market while continuing to generate value through financial and strategic excellence. Moreover, it aims to further drive business success by fostering innovation, enhancing operational efficiency, and promoting collaborative leadership with a specific focus on sustainable and profitable long-term international growth.

About REIG JOFRE, founded in 1929 in Barcelona and dedicated to the research, development, manufacturing, and marketing of pharmaceutical products and food supplements, structures its activities into three business units: Pharmaceutical Technologies (sterile injectables, lyophilized products, and antibiotics), Specialty Pharmacare (dermatology, osteoarticular, women's health, and pediatrics), and Consumer Healthcare (food supplements under the Forté Pharma brand and OTC products). REIG JOFRE employs 1,213 collaborators and operates four development and production centers in Europe (2 in Toledo, 1 in Barcelona, and 1 in Sweden); it has subsidiary companies in 8 countries (Spain, France, Portugal, Belgium, Sweden, the United Kingdom, Poland, and Singapore) and collaborates with 160 commercial partners in more than 70 countries. In 2022, the company achieved a turnover of €271 million.

Further Information

Inma Santa-Pau - Director of Communication and Investor Relations - isantapau@reigjofre.com
www.reigjofre.com

Laboratorio REIG JOFRE, S.A., Gran Capità 10, 08970 Sant Joan Despí (Barcelona), España. CIF A-96184882. R.M. Barcelona. Tomo 44648, Folio 105, Hoja B-462303

Record changed: 2024-01-31

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)